Jump to content

Draft:Spasmolytic A29

From Wikipedia, the free encyclopedia
Spasmolytic A29
Identifiers
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H21N
Molar mass251.373 g·mol−1
3D model (JSmol)
  • CC(C=C(C1=CC=CC=C1)C2=CC=CC=C2)N(C)C

Structure called A29 here:[1][2]

A-29 is not used by itself but is co-administered with ketobemidone in a formulation that is called Ketogan. A29 is a regioisomer of amitriptyline with the bridge ethylene removed. The pharmacology is stated to be NMDA antagonist and not sodium channel blocker activity.

Similar pharmacological compounds to consider include: BW 247 and DPH-362.

References

[edit]
  1. ^ PETERSEN PV (1951). "Studies on a new spasmolytic compound 1,1-diphenyl-3-dimethylaminobutene-1 (A29), related to methadone, and on the combined use of this compound and a potent analgesic, ketobemidone (A21)". Acta Pharmacologica et Toxicologica. 7 (1): 51–64. doi:10.1111/j.1600-0773.1951.tb02849.x. PMID 14829296.
  2. ^ Ebert B, Thorkildsen C, Andersen S, Christrup LL, Hjeds H (September 1998). "Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists". Biochemical Pharmacology. 56 (5): 553–9. doi:10.1016/s0006-2952(98)00088-4. PMID 9783723.